American Science And Engineering, Inc. Receives $25 Million Follow-on Order For Z Portal And OmniView Systems To Secure Critical Infrastructure
Main Category: Public HealthArticle Date: 25 May 2009 - 2:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
American Science and Engineering, Inc. (AS&E®) (NASDAQ: ASEI), a leading worldwide supplier of innovative X-ray detection solutions, announced that it has received a $25 million follow-on order for a Middle East client for multiple Z Portal® cargo and vehicle screening systems and OmniView™ Gantry cargo inspection system to protect critical infrastructure in the region. AS&E's Z Portal and OmniView systems will scan vehicles and trucks entering a high-risk facility in the Middle East for explosive threats and contraband.
"This is a breakthrough critical infrastructure order for us, and demonstrates the value that AS&E solutions provide for high-risk facilities in the Middle East and around the world," said Anthony Fabiano, AS&E President and CEO. "Protecting critical infrastructure is a key element of homeland security for every nation, and we are pleased to work with this client to provide fully integrated solutions to protect this high-threat facility with our proprietary Z Backscatter ™ and Shaped Energy ® technologies."
AS&E has a full range of leading-edge, industry-proven security screening solutions for critical infrastructure that is essential to the function of governments and national defense organizations around the world. Securing these facilities is crucial to protect the safe operation of facilities for electricity, telecommunications, transportation, water supplies, military, police, banking, hospitals, heating, agriculture, oil and gas refineries, and national monuments. AS&E systems for cargo, parcel, and personnel screening are deployed worldwide, helping large governments and corporations protect their vital assets.
AS&E's Z Portal® Cargo & Vehicle Screening System: High-Throughput, Drive-Through Inspection
The Z Portal system is the most comprehensive screening system available with multi-view, drive-through screening for left, right, and top-down imaging of cars, vans, trucks, and their cargo. Z Portal's patented Z Backscatter technology produces photo-like images for superior detection capability of plastic and liquid explosives, narcotics, plastics weapons, drugs, stowaways, and alcohol. With its compact design, the Z Portal system is ideal for high-traffic locations with space constraints and a high-throughput requirement and is safe for drivers, operators, cargo, and the environment. The relocatable screening system is available in two sizes - one for large trucks, buses, and cargo vehicles, and a smaller size for passenger vehicles. Customers include U.S. Department of Defense, U.S. Customs and Border Protection, and NATO.
AS&E's OmniView™ Gantry Cargo & Vehicle Inspection System: High Penetration into Dense Cargo
The OmniView Gantry System is the only multi-view relocatable system available today that combines high-energy transmission inspection plus multiple Z Backscatter X-ray views. OmniView's Shaped Energy technology provides high penetration into complex cargo and dense objects - up to 14 inches (350 mm) of steel - without an exterior building or heavy shielding. Combined with its three-sided multi-view Z Backscatter imaging, OmniView's combination of technologies delivers the most reliable means of detecting contraband and threatening materials such as weapons and explosives hidden in cargo containers, tankers, and large vehicles. Customers include NATO, Abu Dhabi Customs, U.S. Navy, and Port of Charleston as part of a U.S. Department of Justice-sponsored program.
Source
American Science and Engineering, Inc.
Visit our public health section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/151257.php>
APA
http://www.medicalnewstoday.com/releases/151257.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





